Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Alan S. Taylor"'
Autor:
Joseph J. DeGeorge, L. F. Sancilio, M. E. Brower, C. J. Sun, Wendelyn J. Schmidt, S. Williams, W. D. Mcguinn, V. Whitehurst, P. A. Andrews, H. V. Sheevers, Doo Young Lee-Ham, Alan S. Taylor, Chang Ho Ahn, L. Pei, M. Y. Chun, S C Tripathi, T. Du, Y. S. Choi, W. M. Vogel
Publikováno v:
Regulatory Toxicology and Pharmacology. 25:189-193
The standard approaches for the preclinical development of chronically administered drugs also apply to most respiratory drugs. Modifications from the standard preclinical development plan, however, may be necessary if the drug is administered intran
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39e2d598b3313edcc146b8815d0b8d8a
https://doi.org/10.1006/rtph.1997.1099
https://doi.org/10.1006/rtph.1997.1099
Publikováno v:
The Electricity Journal. 8:56-66
There is no “one size fits all” role for renewables in utility resource plans, so the benefits and potential of renewables depend on careful analysis of the specifics of a given utility's situation. As the state of the modeling art advances, and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f60c192cab3d09fa5c424cfa7569cc91
https://doi.org/10.1016/1040-6190(95)90153-1
https://doi.org/10.1016/1040-6190(95)90153-1
Publikováno v:
Drug Information Journal. 30:177-179
When serious adverse effects are observed in preclinical safety studies being conducted after the initial investigational new drug (IND) submission, the sponsor is required to submit an IND safety report, referred to as an S-2 report. This is especia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::37c960ea038e60ac6d7a399fd949d4ec
https://doi.org/10.1177/009286159603000120
https://doi.org/10.1177/009286159603000120
Autor:
Alan S. Taylor, Joseph J. DeGeorge, James G. Farrelly, Albert F. DeFelice, Chang-Ho Ahn, Joy A. Cavagnaro, Alexander Jordan, Lauren E. Black
Publikováno v:
Antisense Research and Development. 4:299-301
This article describes pharmacology and toxicity studies for oligonucleotide drugs that are recommended for inclusion in the initial Investigational New Drug Application (IND), a first request to use an investigational drug in clinical trials. Recent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8704e21229b811bb827eec14e64f4f64
https://doi.org/10.1089/ard.1994.4.299
https://doi.org/10.1089/ard.1994.4.299
Autor:
Wallace P. Adams, Roger L. Williams, Rashmikant M. Patel, Guirag Poochikian, Alan S. Taylor, Gregory P. Burke
Publikováno v:
Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine. 7(2)
Regulatory requirements for modifications to an approved innovator metered dose inhaler (pressurized MDI; USP nomenclature: inhalation aerosol) and for development of a new generic product are discussed. Although many of the requirements apply genera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::343ba88c32850119a878f0f32d3155ec
https://pubmed.ncbi.nlm.nih.gov/10147277
https://pubmed.ncbi.nlm.nih.gov/10147277
Publikováno v:
Prostaglandins. 29:449-458
5,8,11,14-eicosatetraynoic acid (ETYA), a widely used inhibitor of cyclooxygenase and lipoxygenase, inhibited the incorporation of 14C-arachidonic acid into cell lipids of the murine thymoma EL4 whereas oleic acid had no effect. Inhibition appeared t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::163a609e744085359cb5092132637823
https://doi.org/10.1016/0090-6980(85)90102-9
https://doi.org/10.1016/0090-6980(85)90102-9
Publikováno v:
Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 833:229-238
Evidence is presented that the murine thymoma EL4 and cytotoxic T lymphocyte clones possess two distinct long-chain fatty acyl-CoA synthetase activities. One enzyme shows activity toward a broad spectrum of fatty acid substrates, similar to the long-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3f6bb1017ad68e43c7ab630da99b499
https://doi.org/10.1016/0005-2760(85)90195-x
https://doi.org/10.1016/0005-2760(85)90195-x
Autor:
Alan S. Taylor, Eugene M. Johnson
Publikováno v:
Biochemical Pharmacology. 29:113-115
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f569cb9f28595dbec008c52b176e657b
https://doi.org/10.1016/0006-2952(80)90253-1
https://doi.org/10.1016/0006-2952(80)90253-1